|
Market Closed -
Nasdaq
16:00:00 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 2.240 USD | +2.28% |
|
-3.03% | +94.78% |
| Market Cap | 997M 860M 810M 738M 1.38B 94.15B 1.39B 9.59B 3.72B 48.14B 3.74B 3.66B 158B | P/E 2026 * |
-13.4x | P/E 2027 * | -11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 997M 860M 810M 738M 1.38B 94.15B 1.39B 9.59B 3.72B 48.14B 3.74B 3.66B 158B | EV / Sales 2026 * |
26.3x | EV / Sales 2027 * | 50.1x |
| Free-Float |
98.45% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Lexicon Pharmaceuticals, Inc.
| 1 day | +2.28% | ||
| 1 week | -3.03% | ||
| Current month | -0.44% | ||
| 1 month | -3.03% | ||
| 3 months | +18.52% | ||
| 6 months | +43.59% | ||
| Current year | +94.78% |
| 1 week | 2.17 |  | 2.32 |
| 1 month | 1.96 | | 2.52 |
| Current year | 1.1 | | 2.68 |
| 1 year | 1.03 | | 2.68 |
| 3 years | 0.28 | | 3.73 |
| 5 years | 0.28 | | 6.33 |
| 10 years | 0.28 | | 19.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Exton
CEO | Chief Executive Officer | 56 | 2024-07-07 |
Scott Coiante
DFI | Director of Finance/CFO | 59 | 2025-01-01 |
Michael Davies
CTO | Chief Tech/Sci/R&D Officer | - | 2025-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Barker
CHM | Chairman | 83 | 2004-12-31 |
Ray Debbane
CHM | Chairman | 71 | 2012-02-26 |
| Director/Board Member | 67 | 2007-08-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/3/26 | Exercice | Director | 178,624 | 0.0402% | ||
| 6/3/26 | Exercice | Director | 178,624 | 0.0402% | ||
| 6/3/26 | Exercice | Director | 178,624 | 0.0402% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.28% | -3.03% | +100.00% | +32.54% | 974M | |
| +1.03% | -2.05% | +39.28% | +94.60% | 68.21B | |
| +1.62% | +0.33% | +48.61% | +88.33% | 64.25B | |
| +4.21% | +1.80% | -12.85% | +459.32% | 26.54B | |
| +3.68% | +1.39% | +39.97% | +13.90% | 25.9B | |
| +1.83% | -7.77% | +3.17% | -14.74% | 25.61B | |
| +1.30% | +0.74% | +31.66% | -17.99% | 19.88B | |
| -0.38% | -17.67% | +214.37% | +373.18% | 17.13B | |
| +0.93% | -5.05% | -3.02% | +541.34% | 14.93B | |
| +2.88% | +4.33% | +57.42% | +157.39% | 14.1B | |
| Average | +1.98% | -4.33% | +51.86% | +172.79% | 27.75B | |
| Weighted average by Cap. | +1.85% | -3.14% | +42.31% | +146.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.95M 32.74M 30.84M 28.1M 52.52M 3.58B 52.91M 365M 142M 1.83B 142M 139M 6.02B | 19.91M 17.18M 16.18M 14.74M 27.56M 1.88B 27.77M 192M 74.36M 962M 74.78M 73.14M 3.16B |
| Net income | -72.44M -62.49M -58.87M -53.64M -100M -6.84B -101M -697M -270M -3.5B -272M -266M -11.49B | -90.96M -78.47M -73.92M -67.35M -126M -8.59B -127M -875M -340M -4.39B -342M -334M -14.43B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | US$2.240 | +2.28% | 2,335,860 |
| 26-09-01 | US$2.190 | -2.67% | 1,987,900 |
| 26-08-31 | US$2.250 | -1.75% | 6,653,031 |
| 26-08-28 | US$2.290 | -1.29% | 2,679,263 |
| 26-08-27 | US$2.320 | +0.43% | 1,618,340 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXRX Stock
Select your edition
All financial news and data tailored to specific country editions
